Of these metabolites, cysteine‐glutathione disulfide significantly and negatively correlated with ALT, AST, and uric acid levels, indicating that glutathione metabolism has a key role in improving liver functions in NAFLD patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.